OPCH News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

OP

Mkt Cap

$4.67B

Volume

2.42M

Next Earnings

October 29th

Loading chart

OP

OPCHOption Care Health, Inc. Common Stock

OPCH

Pay with—

Available Balance0.00

OP

Mkt Cap

$4.67B

Volume

2.42M

Next Earnings

October 29th

Chart Financials Earnings News About Insider Filings

Strength Seen in Option Care (OPCH): Can Its 32.7% Jump Turn into More Strength?Option Care Health (OPCH) surged 32.7% following the announcement of its acquisition by CD&R and McKesson for $32.05 per share in cash, representing a 37% premium to the previous closing price. The $5.8 billion enterprise value deal underscores the strategic appeal of OPCH's home and alternate-site infusion care platform. However, with unchanged earnings estimate revisions over the past 30 days, analysts caution that sustained momentum may depend on future estimate trends.Zacks Investment Research · Oct 7, 2026

Company News for Oct 7, 2026Several stocks surged following major announcements: AMD rose 2.8% on plans to boost chip production in 2027 for AI demand. Constellation Energy jumped 12.3% after Google signed a $4.3 billion nuclear power deal. Option Care Health soared 32.7% on acquisition news from McKesson and Clayton, Dubilier & Rice. Vistra Corp. gained 10.8% after the Department of Energy committed $4.2 billion for nuclear facility upgrades.Zacks Investment Research · Oct 7, 2026

Halper Sadeh LLC is Investigating Whether PTC and OPCH are Obtaining Fair Deals for their ShareholdersHalper Sadeh LLC, an investor rights law firm, is investigating PTC Inc. and Option Care Health, Inc. for potential violations of federal securities laws and breaches of fiduciary duties relating to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits or terms limiting competing offers are present in these transactions.GlobeNewswire Inc. · Oct 7, 2026

Why Option Care Health Stock Skyrocketed on TuesdayOption Care Health agreed to be acquired by McKesson and private equity firm Clayton, Dubilier & Rice for $32.05 per share, valuing the company at approximately $5.8 billion. The deal represents a 37% premium to Monday's closing price and is expected to close in the first half of 2027. CD&R will hold 51% of the company while McKesson retains 49%, with a framework allowing McKesson to acquire CD&R's stake in the future.The Motley Fool · Oct 6, 2026

Is Option Care Health (OPCH) Stock Undervalued Right Now?Zacks identifies Option Care Health (OPCH) as an attractive value stock opportunity, holding a Zacks Rank #2 (Buy) and Value grade of A. The company trades at a P/E ratio of 15.09, below its industry average of 18.05, and demonstrates favorable valuations across multiple metrics including P/B, P/S, and P/CF ratios compared to industry peers.Zacks Investment Research · Oct 6, 2026

BTSG Deploys AI Across Operations: Will It Improve Margins?BrightSpring Health Services is leveraging AI and automation across hiring, intake, documentation, and patient care to improve productivity. The company reported 44% year-over-year adjusted EBITDA growth with margin expansion to 5.3%, with further benefits expected in late 2026 and early 2027. Peers Option Care Health and Addus HomeCare are similarly implementing AI-driven initiatives to enhance efficiency and reduce operational complexity.Zacks Investment Research · Sep 30, 2026

Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?Zacks highlights two healthcare stocks as strong value investment opportunities: Fresenius SE & Co. (FSNUY) with a Zacks Rank #2 and Value grade A, trading at a P/E of 13.26 below its industry average of 18.36; and Option Care Health (OPCH) also with Rank #2 and Value grade A, trading at a forward P/E of 15.09. Both stocks are presented as undervalued based on multiple valuation metrics including P/S, P/CF, and P/B ratios.Zacks Investment Research · Sep 30, 2026

Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?Quest Diagnostics (DGX) has reached a new 52-week high of $248.65, gaining 42.4% year-to-date with a strong track record of beating earnings estimates. The stock carries a Zacks Rank #2 (Buy) with a B VGM Score, though it trades at a premium valuation of 22.2X current fiscal year EPS versus the industry average of 20.4X. The Medical - Outpatient and Home Healthcare industry is in the top 18% of all industries, providing positive tailwinds for the sector.Zacks Investment Research · Sep 16, 2026

Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth?BrightSpring Health Services (BTSG) reported acute infusion volume growth exceeding 20% year-over-year in Q2, roughly 7-8x the overall infusion market growth rate. The company plans to expand into 12-15 additional states over five years to capitalize on a fragmented $20 billion addressable market. Management is investing in infrastructure, AI-enabled intake, and analytics to support expansion, with the stock up 64% year-to-date and rated as a Zacks Rank #1 Strong Buy.Zacks Investment Research · Sep 4, 2026

Zacks Industry Outlook Highlights DaVita, LifeStance Health, Option Care Health, and Aveanna HealthcareThe Outpatient & Home Healthcare industry is experiencing rapid growth driven by digital transformation, an aging population, and cost-effectiveness advantages. The industry has a Zacks Industry Rank #52 (top 21%) with a forward P/E of 19.1X. Four key stocks are highlighted: LifeStance Health (Rank #2) with 19.7% revenue growth, Option Care Health (Rank #2) with 1.9% revenue growth, Aveanna Healthcare (Rank #2) with 10.6% revenue growth, and DaVita (Rank #3) with 4.7% revenue growth.Zacks Investment Research · Aug 31, 2026

to start trading

OP

OPCHOption Care Health, Inc. Common Stock

OPCH

Pay with—

Available Balance0.00

Your PositionYou don't own any OPCH yet.

Related Tickers

Earnings